Literature DB >> 2380201

Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway.

A Le1, K S Graham, R N Sifers.   

Abstract

The naturally occurring PiZ and Pi NullHong Kong variants of the human secretory protein alpha 1-antitrypsin (AAT) are retained within an early compartment of the secretory pathway. Intracellular degradation of these transport-impaired secretory proteins is initiated 30-45 min following their synthesis and translocation into the endoplasmic reticulum (ER). Interestingly, the overall rate of degradation of the retained mutant protein is significantly accelerated when all subcellular compartments are buffered at pH 6. In contrast, degradation is virtually abolished when intravesicular compartments are buffered at pH 8. However, despite this pH sensitivity neither lysosomotrophic amines, leupeptin, or leucine methyl ester have an apparent effect on the intracellular removal of the PiZ variant. The inability of a variety of inhibitors of ER-to-Golgi protein trafficking to hinder the degradative process suggests that degradation of the PiZ variant occurs prior to its delivery to the Golgi complex. To biochemically map the subcellular site of the degradation of the retained mutant protein, a recombinant truncated PiZ variant containing the tetrapeptide KDEL at its carboxyl terminus (a signal for sorting luminal proteins from a post-ER compartment back to the ER) was expressed in cells. Attachment of this ER-recycling signal to the recombinant protein prevented its intracellular degradation. These findings indicate that degradation of the PiZ variant occurs following its export from the ER.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Misfolded proteins traffic from the endoplasmic reticulum (ER) due to ER export signals.

Authors:  Margaret M Kincaid; Antony A Cooper
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

2.  Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum.

Authors:  M Ito; J L Jameson; M Ito
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids.

Authors:  Yuichiro Shimizu; Yuki Okuda-Shimizu; Linda M Hendershot
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

4.  A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency.

Authors:  Y Wu; I Whitman; E Molmenti; K Moore; P Hippenmeyer; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts.

Authors:  N Enomaa; T Heiskanen; R Halila; R Sormunen; R Seppälä; M Vihinen; L Peltonen
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

6.  Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant alpha1-antitrypsin deficiency.

Authors:  Emer Kelly; Catherine M Greene; Tomás P Carroll; Noel G McElvaney; Shane J O'Neill
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

7.  Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD.

Authors:  Feng Zhou; Jianmin Su; Le Fu; Yong Yang; Lineng Zhang; Liying Wang; Hongbo Zhao; Diancai Zhang; Zengxia Li; Xiliang Zha
Journal:  Glycoconj J       Date:  2008-05-20       Impact factor: 2.916

8.  Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.

Authors:  E Verpy; E Couture-Tosi; E Eldering; M Lopez-Trascasa; P Späth; T Meo; M Tosi
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor.

Authors:  D J Hilton; S S Watowich; P J Murray; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

Review 10.  How early studies on secreted and membrane protein quality control gave rise to the ER associated degradation (ERAD) pathway: the early history of ERAD.

Authors:  Patrick G Needham; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta       Date:  2013-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.